Noriko Umemoto

1.1k total citations
19 papers, 905 citations indexed

About

Noriko Umemoto is a scholar working on Cell Biology, Molecular Biology and Physiology. According to data from OpenAlex, Noriko Umemoto has authored 19 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cell Biology, 9 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Noriko Umemoto's work include Zebrafish Biomedical Research Applications (12 papers), Pluripotent Stem Cells Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Noriko Umemoto is often cited by papers focused on Zebrafish Biomedical Research Applications (12 papers), Pluripotent Stem Cells Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Noriko Umemoto collaborates with scholars based in Japan, United Arab Emirates and Germany. Noriko Umemoto's co-authors include Yuhei Nishimura, Yasuhito Shimada, Toshio Tanaka, Junya Kuroyanagi, Takehiko Oka, Liqing Zang, Minoru Hirano, Norihiro Nishimura, Zhipeng Wang and Soichiro Murakami and has published in prestigious journals such as PLoS ONE, Biomaterials and FEBS Letters.

In The Last Decade

Noriko Umemoto

19 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noriko Umemoto Japan 15 395 372 181 104 93 19 905
Junya Kuroyanagi Japan 16 399 1.0× 376 1.0× 244 1.3× 186 1.8× 99 1.1× 22 980
Shintaro Imamura Japan 19 286 0.7× 900 2.4× 214 1.2× 158 1.5× 154 1.7× 32 1.4k
Jo Vanoevelen Belgium 24 600 1.5× 1.2k 3.3× 152 0.8× 60 0.6× 55 0.6× 45 1.8k
Bryce A. Mendelsohn United States 16 117 0.3× 561 1.5× 106 0.6× 81 0.8× 90 1.0× 28 1.0k
Kim McGinnis United States 16 401 1.0× 968 2.6× 150 0.8× 113 1.1× 110 1.2× 28 1.5k
Caroline J. Speed Australia 17 239 0.6× 655 1.8× 75 0.4× 35 0.3× 113 1.2× 22 1.5k
Malena B. Rone Canada 17 113 0.3× 845 2.3× 257 1.4× 70 0.7× 71 0.8× 20 1.5k
Martin‐Paul Agbaga United States 23 136 0.3× 1.2k 3.1× 150 0.8× 96 0.9× 191 2.1× 60 1.9k
Antonio Valencia United States 19 272 0.7× 861 2.3× 157 0.9× 69 0.7× 241 2.6× 29 1.6k

Countries citing papers authored by Noriko Umemoto

Since Specialization
Citations

This map shows the geographic impact of Noriko Umemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Umemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Umemoto more than expected).

Fields of papers citing papers by Noriko Umemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Umemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Umemoto. The network helps show where Noriko Umemoto may publish in the future.

Co-authorship network of co-authors of Noriko Umemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Umemoto. A scholar is included among the top collaborators of Noriko Umemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Umemoto. Noriko Umemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Inoue, Atsuto, Yuhei Nishimura, Noriko Umemoto, et al.. (2016). Comparative study of the zebrafish embryonic toxicity test and mouse embryonic stem cell test to screen developmental toxicity of human pharmaceutical drugs. Fundamental Toxicological Sciences. 3(2). 79–87. 17 indexed citations
2.
Shimada, Yasuhito, Beibei Zhang, Yasuhiko Shiina, et al.. (2015). E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish. Nutrition & Metabolism. 12(1). 17–17. 46 indexed citations
4.
Zhang, Beibei, Yasuhito Shimada, Junya Kuroyanagi, et al.. (2015). In vivo selective imaging and inhibition of leukemia stem-like cells using the fluorescent carbocyanine derivative, DiOC5(3). Biomaterials. 52. 14–25. 8 indexed citations
5.
Kuroyanagi, Junya, Yasuhito Shimada, Beibei Zhang, et al.. (2014). Zinc finger MYND‐type containing 8 promotes tumour angiogenesis via induction of vascular endothelial growth factor‐A expression. FEBS Letters. 588(18). 3409–3416. 19 indexed citations
6.
Zhang, Beibei, Yasuhito Shimada, Junya Kuroyanagi, et al.. (2014). Quantitative Phenotyping-Based In Vivo Chemical Screening in a Zebrafish Model of Leukemia Stem Cell Xenotransplantation. PLoS ONE. 9(1). e85439–e85439. 51 indexed citations
7.
Umemoto, Noriko, Yasuhito Shimada, Yuhei Nishimura, et al.. (2014). Downregulation of Stanniocalcin 1 Is Responsible for Sorafenib-Induced Cardiotoxicity. Toxicological Sciences. 143(2). 374–384. 25 indexed citations
8.
Zhang, Beibei, Yasuhito Shimada, Junya Kuroyanagi, et al.. (2014). Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors. Tumor Biology. 35(12). 11861–11869. 33 indexed citations
9.
Nishimura, Yuhei, Soichiro Murakami, Yoshifumi Ashikawa, et al.. (2014). Zebrafish as a systems toxicology model for developmental neurotoxicity testing. Congenital Anomalies. 55(1). 1–16. 158 indexed citations
10.
Shimada, Yasuhito, et al.. (2013). Downregulation of Max dimerization protein 3 is involved in decreased visceral adipose tissue by inhibiting adipocyte differentiation in zebrafish and mice. International Journal of Obesity. 38(8). 1053–1060. 14 indexed citations
11.
Umemoto, Noriko, Yuhei Nishimura, Yasuhito Shimada, et al.. (2013). Fluorescent-Based Methods for Gene Knockdown and Functional Cardiac Imaging in Zebrafish. Molecular Biotechnology. 55(2). 131–142. 13 indexed citations
12.
Nishimura, Yuhei, Kenichiro Yata, Kohei Watanabe, et al.. (2013). Identification of a Novel Indoline Derivative for in Vivo Fluorescent Imaging of Blood-Brain Barrier Disruption in Animal Models. ACS Chemical Neuroscience. 4(8). 1183–1193. 25 indexed citations
13.
Watanabe, Kohei, Yuhei Nishimura, Noriko Umemoto, et al.. (2012). In vivoassessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish. BMC Neuroscience. 13(1). 101–101. 39 indexed citations
14.
Oka, Takehiko, Yuhei Nishimura, Liqing Zang, et al.. (2010). Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiology. 10(1). 21–21. 310 indexed citations
15.
Watanabe, Kohei, Yuhei Nishimura, Takehiko Oka, et al.. (2010). In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives. BMC Neuroscience. 11(1). 116–116. 36 indexed citations
16.
Wang, Zhipeng, Yuhei Nishimura, Yasuhito Shimada, et al.. (2009). Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation. Gene. 446(1). 18–27. 66 indexed citations
17.
Ito, Yoshiyuki, Minoru Hirano, Noriko Umemoto, et al.. (2008). Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. BMB Reports. 41(2). 139–145. 10 indexed citations
18.
Tanaka, Toshio, Takehiko Oka, Yasuhito Shimada, et al.. (2008). Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models. Journal of Pharmacological Sciences. 107(1). 8–14. 19 indexed citations
19.
Umemoto, Noriko, et al.. (2000). Investigation of Outpatients' Compliance with Medication After Meal and Analysis of Factors on their Noncompliance.. Japanese Journal of Hospital Pharmacy. 26(1). 79–86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026